SPALLONE, VINCENZA
 Distribuzione geografica
Continente #
NA - Nord America 40.329
EU - Europa 5.116
AS - Asia 3.866
SA - Sud America 676
AF - Africa 88
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 16
Totale 50.176
Nazione #
US - Stati Uniti d'America 40.064
IT - Italia 1.842
SG - Singapore 1.661
CN - Cina 719
UA - Ucraina 558
DE - Germania 536
BR - Brasile 496
FR - Francia 417
RU - Federazione Russa 379
IE - Irlanda 352
VN - Vietnam 332
HK - Hong Kong 302
KR - Corea 257
GB - Regno Unito 235
PL - Polonia 174
FI - Finlandia 168
SE - Svezia 128
MX - Messico 127
JP - Giappone 113
CA - Canada 101
NL - Olanda 94
IN - India 85
ES - Italia 76
AU - Australia 69
ID - Indonesia 55
TR - Turchia 51
AR - Argentina 42
BD - Bangladesh 40
CO - Colombia 35
TH - Thailandia 35
ZA - Sudafrica 33
IQ - Iraq 30
PH - Filippine 28
CL - Cile 26
CH - Svizzera 25
KG - Kirghizistan 24
MY - Malesia 24
PE - Perù 24
EC - Ecuador 22
BE - Belgio 20
PK - Pakistan 20
AT - Austria 16
EG - Egitto 16
IR - Iran 16
NZ - Nuova Zelanda 15
UZ - Uzbekistan 15
HU - Ungheria 14
DK - Danimarca 12
EU - Europa 12
RO - Romania 12
CZ - Repubblica Ceca 10
BG - Bulgaria 9
GR - Grecia 9
PY - Paraguay 9
VE - Venezuela 9
CR - Costa Rica 8
MA - Marocco 8
TW - Taiwan 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
KE - Kenya 6
SA - Arabia Saudita 6
UY - Uruguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
GT - Guatemala 5
IL - Israele 5
LT - Lituania 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
MN - Mongolia 4
AM - Armenia 3
BB - Barbados 3
GE - Georgia 3
JM - Giamaica 3
MD - Moldavia 3
NP - Nepal 3
PR - Porto Rico 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CG - Congo 2
CM - Camerun 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
ME - Montenegro 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BY - Bielorussia 1
Totale 50.164
Città #
Wilmington 11.063
Woodbridge 10.987
Houston 9.999
Singapore 995
Fairfield 804
Chandler 725
Ann Arbor 586
Ashburn 573
Jacksonville 410
San Jose 403
Dublin 330
Beijing 291
Hong Kong 291
Seattle 284
Cambridge 265
Medford 246
Rome 235
Dearborn 215
New York 186
Kraków 153
The Dalles 144
Santa Clara 132
Lawrence 117
Council Bluffs 111
Ho Chi Minh City 110
Milan 109
Los Angeles 106
Redwood City 104
Tokyo 85
Menlo Park 80
Dallas 78
Lauterbourg 78
Hanoi 69
Helsinki 68
Buffalo 53
San Diego 51
Moscow 45
São Paulo 44
Mülheim 38
Florence 36
Jakarta 36
London 36
Naples 34
Boardman 33
Bologna 33
Mountain View 33
Falls Church 32
Toronto 32
Bangkok 28
Nuremberg 28
Zhengzhou 28
Phoenix 27
Redondo Beach 27
Orem 26
Palo Alto 26
Atlanta 25
Bari 23
Sydney 23
University Park 23
Verona 23
Munich 22
Palermo 22
Santiago 22
Da Nang 21
Ankara 20
Denver 20
Dong Ket 20
Guangzhou 20
Lima 20
Barcelona 19
Boston 19
Kunming 19
Frankfurt am Main 18
Nanjing 18
Shanghai 18
Padova 17
Brussels 16
Columbus 16
Detroit 16
Modena 16
Montreal 16
Brasília 15
Calgary 15
Trieste 15
Warsaw 15
Amsterdam 14
Chicago 14
Kansas City 14
Mumbai 14
Norwalk 14
Bogotá 13
Budapest 13
Johannesburg 13
Madrid 13
Melbourne 13
Newark 13
Stockholm 13
Turin 13
Baghdad 12
Hefei 12
Totale 41.928
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 1.319
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 958
Neuropatia Diabetica 648
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 571
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 530
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 524
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 524
Neuropatia Diabetica 523
Il trattamento della psoriasi nell’adulto. Linea guida 25. 523
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 516
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 510
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 502
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 499
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 496
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 492
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 485
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 485
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 484
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 480
Combination Therapy in Diabetic Neuropathy 479
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 474
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 471
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 471
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 467
Diagnosis of cardiovascular autonomic neuropathy in diabetes 466
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 466
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 466
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 465
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 464
Effects of somatostatin on established induced ketosis 464
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 459
Neuropatia e assistenza al diabetico 459
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 458
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 454
Benfotiamine: Commentary and update on recent studies 454
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 453
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 451
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 449
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 448
Carbohydrate metabolism in hypertension: influence of treatment 448
Autonomic neuropathy: Clinical and instrumental findings 445
Neuropathy in chronic kidney disease 443
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 441
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 441
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 440
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 439
Neuropatia diabetica in Italia 436
The relationship of autonomic neuropathy to other diabetic complications 432
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 431
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 430
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 429
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 426
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 425
Study of conduction velocity in diabetic with autonomic neuropathy. 424
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 424
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 424
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 423
Methods of investigation for cardiac autonomic dysfunction in human research studies 423
Management of painful diabetic neuropathy: guideline guidance or jungle? 423
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 421
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 419
Might genetics play a role in understanding and treating diabetic polyneuropathy? 419
Efficacy and safety of lacosamide in painful diabetic neuropathy 417
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 416
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 414
Diabetic autonomic neuropathy 411
MicroRNA genetic variations: association with type 2 diabetes 411
Painful and painless diabetic neuropathy: one disease or two? 411
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 411
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 408
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 403
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 403
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 401
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 400
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 399
Il corretto iter diagnostico della Neuropatia Diabetica 392
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 392
Le nuove frontiere della nutrizione. 387
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 387
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 386
Reply to Circulating erythropoietin in diabetes mellitus. 384
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 383
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 381
Costruire l'identità del nutrizionista 379
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 378
Comparative study of periferal and autonomic neuropathy in diabetes 377
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 376
Screening e trattamento della neuropatia diabetica 376
Time for a Consensus Conference on pain in neurorehabilitation. 376
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 374
Terapia farmacologica della neuropatia diabetica dolorosa 370
Microvascular complications in children and adolescents with type 1 diabetes 367
Blood Pressure Variability and Autonomic Dysfunction 365
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 364
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 362
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 361
Disfunzione autonomica gastro-enterica e genito-urinaria 360
Impaired alpha cell function in conditions with cortisol deficiency 357
Glycaemic control and gastric emptying 356
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 346
Totale 44.854
Categoria #
all - tutte 100.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021375 0 0 0 0 0 0 0 0 0 0 278 97
2021/20221.378 48 178 76 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/20241.016 100 54 72 78 105 175 49 69 55 75 69 115
2024/20252.896 135 664 304 202 136 146 257 145 374 211 213 109
2025/20264.411 297 194 516 460 488 200 695 508 617 435 1 0
Totale 50.640